Clinical trial 470 x 80 (new)

NeuroSearch files CTA for the initiation of a clinical Phase III programme

1 October - NeuroSearch has filed a Clinical Trial Application in Europe for the initiation of Phase III clinical studies with the drug candidate ACR16 for the treatment of Huntington's disease. Read more

Lu AA21004 shows highly significant results in clinical phase II trial

2 October - H. Lundbeck A/S announces positive headline results from a newly unblinded proof of concept clinical study with the compound Lu AA21004 for the treatment of Major Depressive Disorder.  Read more